Recombinant Human CLEC11A Protein，His & GST

CLEC11A (C-type lectin domain family 11 member A) is a protein that has garnered significant attention in recent years due to its potential roles in various biological processes and diseases. Initially identified as a protein involved in the regulation of immune responses, CLEC11A has been implicated in the differentiation and maturation of myeloid cells, influencing both innate and adaptive immunity. Research has shown that CLEC11A can modulate the activity of dendritic cells and macrophages, which are crucial for initiating immune responses. Furthermore, its expression has been associated with certain pathological conditions, including cancer, where it may affect tumor in stromal interactions and immune evasion mechanisms. Given its multifunctional nature, the recombinant expression of CLEC11A presents an opportunity for further investigations into its functional roles. Studies focusing on CLEC11A recombinant protein aim to elucidate its binding mechanisms, signaling pathways, and interactions with other cellular components. By understanding the structural and functional properties of CLEC11A, researchers hope to identify its potential as a therapeutic target or biomarker in diseases such as cancer and autoimmune disorders. The ongoing research into CLEC11A reinforces the significance of this protein in both basic and applied biomedical sciences, highlighting its potential implications in improving disease management and treatment strategies.